ClinicalTrials.gg
Status unknownNCT05713539Updated Feb 6, 2023

Determining Whether There is a Change in Time Taken to Return to Homeostatic Temperature With Repeated Exposure to a Cold Stressor

An interventional study of Metal block in Needle Phobia, Needle Fear and Injection Fear, sponsored by The Whiteley Clinic. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-06.

Sponsored by The Whiteley Clinic · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Feb 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

There has been previous research suggesting cold has an effect on pain relief, however there is limited knowledge on the relationship between exposure time of a cold stressor and how long it takes to return to homeostatic temperature and normal response to cold, in addition to whether location site affects this. The skin's thermal response to a cold stimulus is not fully understood. This provides precedent for potentially using cold stressors as a way to provide pain free injections.

5 participants will be exposed to a block of copper on the skin at -2°C for 30 seconds, and a thermal camera will be used to identify the amount of time it takes for the skin to return to its homeostatic temperature. The participant will then be left for 30 seconds before the experiment is repeated to identify if there is a change in the response to cold after the first exposure.

If increased sensitivity in the response to cold occurs, the experiment will be repeated by adding an additional 30 seconds between repeats to identify the minimum time required between exposures that doesn't result in increased sensitivity. This will occur until there are two consecutive times with no increased sensitivity.

This will occur on both the forehead and on the deltoid of the arm, two areas where injections are common.

The cold stressor will be block of copper metal which will be cooled to this temperature.

Read the detailed description

A thermal imaging camera is used to identify the 'normal' temperature of the skin on the forehead. A cooled block of copper is then placed onto the skin of the forehead at a temperature of -2°C for 30 seconds. A timer is then used to measure how long it takes for the skin on the forehead to return to its normal temperature. This is then repeated twice with a minute in between each measurement to identify if there is a change in the response to cold, where it takes more/less time to return to normal levels. If the time taken to return to normal changes, the participant will be given 30 minutes to rest, and then repeat the experiment with an additional minute between repeats. This will continue until there is no change in the amount of time it takes for the skin to return to normal on the forehead once exposed to the cold conditions to identify a sensitivity time due to a change in the response to cold. This will be tested on 5 patients.

This will also be tested on the outer deltoid, where injections usually occur in your arm.

02

Conditions studied

  • Needle Phobia
  • Needle Fear
  • Injection Fear

Keywords

  • pain
  • cold
  • skin response
  • injections
03

In context

Iatrophobia

23 studies on the registry are indexed under Iatrophobia; 8 are open to participants now.

This study's planned enrollment of 5 is below the median of 90 across 21 interventional studies indexed under Iatrophobia.

Browse Iatrophobia studies →

Lead sponsor

The Whiteley Clinic is the lead sponsor of 15 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Able to give
  • Above 18 years old

Exclusion criteria

Exclusion Criteria:

  • Skin conditions or irregularities, or on medication that affects temperature regulation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (estimated)

Study arms

  • Experimental
    Cooled metal placed on skin

    Metal is placed onto the skin at a temperature of -2 degrees Celsius for 30 seconds. A thermal imaging camera will be used to identify how long it takes for the skin to return to its initial temperature.

    Other: Metal block

Interventions

  • OtherMetal block

    Small sheet of copper will be used when cooled to the designated temperature

06

What researchers measure

Primary outcomes

  1. Measuring the time it takes to return to homeostatic temperature when exposed to cold.

    To identify if there is sensitivity (change in response to cold) between repeats when a cold stressor when placed onto the skin which changes the amount of time it takes for the skin to return to its normal temperature

    Time frame: 1 week

Secondary outcomes

  1. To calculate the length of normal response time of skin to cold by looking at time it takes to return to homeostatic temperature in response to multiple cold exposures

    If there is a change in response to cold, to identify how long this lasts for

    Time frame: 1 week

07

Study locations

1 site
  • The Whiteley Clinic
    Guildford, GU2 7RF, United Kingdom
08

References and documents

Individual participant data

Plan to share: No — Not planned

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05713539
Lead sponsor
The Whiteley Clinic
Responsible party
Mark Whiteley (Consultant Venous Surgeon, The Whiteley Clinic) — Principal investigator
First posted
Feb 6, 2023
Start date
Feb 2023 (estimated)
Primary completion
Feb 2023 (estimated)
Completion
Feb 2023 (estimated)
Last update
Feb 6, 2023

Study contacts

Mark S Whiteley, MS FRCS (Gen) MB BS
Contact
mark@thewhiteleyclinic.co.uk
03300581850
Melissa J Kiely, BSc (Hons)
Contact
melissa.kiely@thewhiteleyclinic.co.uk
01483544960
Mark S Whiteley, MS FRCS (Gen) MB BS
principal investigator · Executive Chairman

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion